View Johnson & Johnson's Q3 Earnings Report
FiercePharma says: Market reaction to Johnson & Johnson's earnings announcement reflects an overall worry about cost-cutting versus sales growth. Yes, J&J beat expectations, posting earnings of $1.20 per share, about 7 cents higher than analysts had estimated. But third-quarters sales came in at $15.1 billion, which fell short of those same estimates. At press time, the stock had fallen 2.62 percent, or $1.64, to $60.89. Read more of our coverage here...
- Sales of $15.1 Billion Decreased 5.3% Versus 2008 Third Quarter
- EPS of $1.20 increased 2.6% Versus 2008 Third Quarter
J&J's Website: http://www.jnj.com/connect/